Acquired Methemoglobinemia Treatment Market Will Generate New Growth Opportunities by 2026
Methemoglobinemia is a condition when more than 1% of hemoglobin in the blood gets oxidized to methamoglobin, which is an abnormal form of hemoglobin unable to bind the oxygen molecules. The iron atom gets oxidized from the ferrous state (Fe2+) to the ferric state (Fe3+), losing an electron to an oxidant. This results in anemia, cyanosis, dizziness, fatigue, headache, dyspnea on exertion, and tachycardia. When the levels of methamoglobin in the blood exceeds 50%, it can cause dysrhythmias, hypotension, acidosis,...
View full press release